Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 14,660 | 8,278 | 17,823 | 9,469 | 7,152 |
| Gross Profit | 14,660 | 8,278 | 17,823 | 9,469 | 7,152 |
| Operating Expenses | 33,669 | 33,121 | 28,440 | 25,886 | 26,332 |
| Operating Income | -19,009 | -24,843 | -10,617 | -16,417 | -19,180 |
| Interest Expense | 858 | -2,354 | 2,317 | 2,955 | 1,056 |
| Other Income | -10,492 | -36,952 | 30,073 | 49,244 | 641 |
| Pre-tax Income | -30,359 | -59,441 | 17,139 | 29,872 | -19,595 |
| Net Income Continuous | -30,359 | -59,544 | 17,139 | 29,872 | -19,595 |
| Net Income | $-30,359 | $-59,544 | $17,139 | $29,872 | $-19,595 |
| EPS Basic Total Ops | -6.60 | -16.10 | 4.60 | 10.00 | -8.40 |
| EPS Basic Continuous Ops | -6.61 | -16.05 | 4.65 | 9.99 | -8.45 |
| EPS Diluted Total Ops | -6.60 | -15.40 | 4.50 | 9.40 | -8.40 |
| EPS Diluted Continuous Ops | -6.61 | -15.34 | 4.52 | 9.40 | -8.45 |
| EBITDA(a) | $-17,222 | $-23,474 | $-9,411 | $-15,263 | $-18,122 |